Indication
Hemophilia A
Hemophilia A is an inherited bleeding disorder caused by a congenital deficiency or functional defect of coagulation factor VIII, an essential cofactor in the intrinsic clotting cascade. Read more about Hemophilia A
77 drugs 39 manufacturers
Drugs that treat it
Common Hemophilia A therapies.
KOATE (antihemophilic factor, human)
DESMOPRESSIN ACETATE
XYNTHA (antihemophilic factor (factor VIII) recomb,B-domain deleted)
XYNTHA SOLOFUSE (antihemophilic factor (factor VIII) recomb,B-domain deleted)
ELOCTATE (antihemophilic factor (FVIII) recombinant, Fc fusion protein)
JIVI (antihemophilic factor (FVIII) rec, B-domain deleted peg-aucl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHemophilia A is an inherited bleeding disorder caused by a congenital deficiency or functional defect of coagulation factor VIII, an essential cofactor in the intrinsic clotting cascade.
Transmitted as an X-linked recessive trait, it predominantly affects males, while females are typically asymptomatic or mildly symptomatic carriers.
The condition impairs secondary hemostasis, predisposing patients to prolonged or excessive hemorrhage following trauma or invasive procedures.
Depending on baseline plasma factor VIII activity, clinical manifestations range from excessive post-surgical bleeding in mild disease to recurrent spontaneous hemorrhages—most characteristically painful hemarthroses and deep muscle hematomas that can lead to chronic arthropathy—in severe cases.
- nih.gov
Hemophilia A is an inherited bleeding disorder caused by a congenital deficiency or functional defect of coagulation factor VIII, an essential cofactor in the intrinsic clotting cascade Depending on baseline plasma factor VIII activity, clinical manifestations range from excessive post-surgical bleeding in mild disease to recurrent spontaneous hemorrhages—most characteristically painful hemarthroses and deep muscle hematomas that can lead to chronic arthropathy—in severe cases
- medlineplus.gov
Hemophilia A is an inherited bleeding disorder caused by a congenital deficiency or functional defect of coagulation factor VIII, an essential cofactor in the intrinsic clotting cascade The condition impairs secondary hemostasis, predisposing patients to prolonged or excessive hemorrhage following trauma or invasive procedures Depending on baseline plasma factor VIII activity, clinical manifestations range from excessive post-surgical bleeding in mild disease to recurrent spontaneous hemorrhages...
- medlineplus.gov
Transmitted as an X-linked recessive trait, it predominantly affects males, while females are typically asymptomatic or mildly symptomatic carriers
- nih.gov
Transmitted as an X-linked recessive trait, it predominantly affects males, while females are typically asymptomatic or mildly symptomatic carriers The condition impairs secondary hemostasis, predisposing patients to prolonged or excessive hemorrhage following trauma or invasive procedures Depending on baseline plasma factor VIII activity, clinical manifestations range from excessive post-surgical bleeding in mild disease to recurrent spontaneous hemorrhages—most characteristically painful hemar...
Personalize your experience
Follow Hemophilia A and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.